vs
Side-by-side financial comparison of HARROW, INC. (HROW) and STURM RUGER & CO INC (RGR). Click either name above to swap in a different company.
STURM RUGER & CO INC is the larger business by last-quarter revenue ($151.1M vs $89.1M, roughly 1.7× HARROW, INC.). On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 3.6%). STURM RUGER & CO INC produced more free cash flow last quarter ($12.3M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 5.1%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.
HROW vs RGR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $151.1M |
| Net Profit | $6.6M | — |
| Gross Margin | 79.3% | 17.8% |
| Operating Margin | 17.5% | 2.3% |
| Net Margin | 7.4% | — |
| Revenue YoY | 33.3% | 3.6% |
| Net Profit YoY | -2.2% | — |
| EPS (diluted) | $0.20 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.1M | $151.1M | ||
| Q3 25 | $71.6M | $126.8M | ||
| Q2 25 | $63.7M | $132.5M | ||
| Q1 25 | $47.8M | $135.7M | ||
| Q4 24 | $66.8M | $145.8M | ||
| Q3 24 | $49.3M | $122.3M | ||
| Q2 24 | $48.9M | $130.8M | ||
| Q1 24 | $34.6M | $136.8M |
| Q4 25 | $6.6M | — | ||
| Q3 25 | $1.0M | $1.6M | ||
| Q2 25 | $5.0M | $-17.2M | ||
| Q1 25 | $-17.8M | $7.8M | ||
| Q4 24 | $6.8M | — | ||
| Q3 24 | $-4.2M | $4.7M | ||
| Q2 24 | $-6.5M | $8.3M | ||
| Q1 24 | $-13.6M | $7.1M |
| Q4 25 | 79.3% | 17.8% | ||
| Q3 25 | 75.3% | 15.1% | ||
| Q2 25 | 74.5% | 3.9% | ||
| Q1 25 | 67.5% | 22.0% | ||
| Q4 24 | 78.8% | 22.8% | ||
| Q3 24 | 75.6% | 18.5% | ||
| Q2 24 | 74.4% | 22.3% | ||
| Q1 24 | 69.5% | 21.5% |
| Q4 25 | 17.5% | 2.3% | ||
| Q3 25 | 20.6% | -2.7% | ||
| Q2 25 | 17.9% | -15.6% | ||
| Q1 25 | -23.5% | 6.2% | ||
| Q4 24 | 19.3% | 7.8% | ||
| Q3 24 | 2.7% | 3.1% | ||
| Q2 24 | 3.1% | 6.9% | ||
| Q1 24 | -20.0% | 5.5% |
| Q4 25 | 7.4% | — | ||
| Q3 25 | 1.4% | 1.2% | ||
| Q2 25 | 7.8% | -13.0% | ||
| Q1 25 | -37.2% | 5.7% | ||
| Q4 24 | 10.1% | — | ||
| Q3 24 | -8.6% | 3.9% | ||
| Q2 24 | -13.2% | 6.3% | ||
| Q1 24 | -39.2% | 5.2% |
| Q4 25 | $0.20 | $0.22 | ||
| Q3 25 | $0.03 | $0.10 | ||
| Q2 25 | $0.13 | $-1.05 | ||
| Q1 25 | $-0.50 | $0.46 | ||
| Q4 24 | $0.19 | $0.62 | ||
| Q3 24 | $-0.12 | $0.28 | ||
| Q2 24 | $-0.18 | $0.47 | ||
| Q1 24 | $-0.38 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $92.5M |
| Total DebtLower is stronger | $250.0M | — |
| Stockholders' EquityBook value | $52.4M | $283.8M |
| Total Assets | $399.5M | $342.0M |
| Debt / EquityLower = less leverage | 4.77× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $72.9M | $92.5M | ||
| Q3 25 | $74.3M | $80.8M | ||
| Q2 25 | $53.0M | $101.4M | ||
| Q1 25 | $66.7M | $108.3M | ||
| Q4 24 | $47.2M | $105.5M | ||
| Q3 24 | $72.6M | $96.0M | ||
| Q2 24 | $71.0M | $105.6M | ||
| Q1 24 | $76.0M | $115.3M |
| Q4 25 | $250.0M | — | ||
| Q3 25 | $347.2M | — | ||
| Q2 25 | $250.6M | — | ||
| Q1 25 | $256.9M | — | ||
| Q4 24 | $262.7M | — | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — | ||
| Q1 24 | $243.4M | — |
| Q4 25 | $52.4M | $283.8M | ||
| Q3 25 | $47.0M | $279.6M | ||
| Q2 25 | $49.7M | $289.3M | ||
| Q1 25 | $56.5M | $321.5M | ||
| Q4 24 | $69.7M | $319.6M | ||
| Q3 24 | $58.0M | $314.9M | ||
| Q2 24 | $58.5M | $321.5M | ||
| Q1 24 | $60.6M | $332.0M |
| Q4 25 | $399.5M | $342.0M | ||
| Q3 25 | $363.1M | $342.3M | ||
| Q2 25 | $345.0M | $349.5M | ||
| Q1 25 | $364.2M | $379.0M | ||
| Q4 24 | $389.0M | $384.0M | ||
| Q3 24 | $351.5M | $373.5M | ||
| Q2 24 | $306.6M | $376.7M | ||
| Q1 24 | $295.5M | $385.0M |
| Q4 25 | 4.77× | — | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — | ||
| Q1 24 | 4.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | $15.5M |
| Free Cash FlowOCF − Capex | $8.1M | $12.3M |
| FCF MarginFCF / Revenue | 9.1% | 8.2% |
| Capex IntensityCapex / Revenue | 0.4% | 2.1% |
| Cash ConversionOCF / Net Profit | 1.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | $38.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.4M | $15.5M | ||
| Q3 25 | $16.6M | $12.9M | ||
| Q2 25 | $-803.0K | $14.7M | ||
| Q1 25 | $19.7M | $11.1M | ||
| Q4 24 | $-17.8M | $20.0M | ||
| Q3 24 | $3.0M | $9.4M | ||
| Q2 24 | $-2.7M | $18.7M | ||
| Q1 24 | $-4.6M | $7.3M |
| Q4 25 | $8.1M | $12.3M | ||
| Q3 25 | $16.4M | $7.0M | ||
| Q2 25 | $-969.0K | $9.1M | ||
| Q1 25 | $19.5M | $10.0M | ||
| Q4 24 | $-18.3M | $16.4M | ||
| Q3 24 | $2.3M | $2.6M | ||
| Q2 24 | $-3.1M | $10.1M | ||
| Q1 24 | $-4.7M | $5.6M |
| Q4 25 | 9.1% | 8.2% | ||
| Q3 25 | 22.9% | 5.5% | ||
| Q2 25 | -1.5% | 6.9% | ||
| Q1 25 | 40.8% | 7.4% | ||
| Q4 24 | -27.4% | 11.2% | ||
| Q3 24 | 4.8% | 2.1% | ||
| Q2 24 | -6.3% | 7.7% | ||
| Q1 24 | -13.6% | 4.1% |
| Q4 25 | 0.4% | 2.1% | ||
| Q3 25 | 0.3% | 4.6% | ||
| Q2 25 | 0.3% | 4.2% | ||
| Q1 25 | 0.4% | 0.8% | ||
| Q4 24 | 0.8% | 2.5% | ||
| Q3 24 | 1.2% | 5.5% | ||
| Q2 24 | 0.7% | 6.6% | ||
| Q1 24 | 0.3% | 1.3% |
| Q4 25 | 1.27× | — | ||
| Q3 25 | 16.26× | 8.15× | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | -2.62× | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HROW
Segment breakdown not available.
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
